Yoga Intervention for Substance Use and ART Adherence in Community Reentry

Not Applicable

Completed

• Conditions: Substance Related Disorders; HIV
• Interventions: Other: Hatha yoga

• Registration Number: NCT02492893
• Lead Sponsor: University of Pennsylvania

Brief Summary

People with HIV and a substance use disorder who are reentering the community from prison or jail face the dual risks of relapse and interruptions in adherence to antiretroviral therapy (ART) medication. This mixed-methods randomized controlled trial will compare the stress, substance use and ART adherence outcomes of participants in a 12-session, 90-minute weekly yoga group intervention with participants in a treatment as usual control group. All participants are re-entering the community, have HIV and experience substance use challenges.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-12
• Study First Submitted: 2015-06-19
• Study First Submitted QC: 2015-07-06
• Study First Posted: 2015-07-09
• Primary Completion: 2016-02
• Study Completion: 2016-02
• Status Verified: 2017-04
• Last Update Submitted: 2017-04-14
• Last Update Posted: 2017-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

• have HIV
• experience substance use challenges, within one year of reentry from prison or jail

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Hatha Yoga	Hatha yoga	A 12-session 90-minute weekly hatha yoga intervention, that includes asanas (physical postures), pranayama (breathing exercises) and dhyana (meditation.

Primary Outcome Measures

Name	Time	Method
Substance use: Time Line Follow Back (self-report)	3 months
Stress: Perceived Stress Scale (self-report)	3 months

Secondary Outcome Measures

Name	Time	Method
Antiretroviral therapy adherence: prescription refill (pharmacy data)	3 months
Heart rate: sphygmomanometer	3 months
Blood pressure: sphygmomanometer	3 months
Viral load: blood test	3 months

Trial Locations

Locations (1)

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States